Antiproliferative therapy with sirolimus and propranolol for congenital vascular anomalies in newborns (Case reports)-Reference-Cited by-同舟云学术

Antiproliferative therapy with sirolimus and propranolol for congenital vascular anomalies in newborns (Case reports)

Published:2021-08-02 Issue:4 Volume:22 Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Cîrstoveanu Cătălin¹,Bizubac Ana¹,Mustea Cristina¹,Manolache Ștefan¹,Istrate‑Bârzan Alexandra¹,Sfrijan Doinița²,Marcu Veronica³,Iozsa Dan-Alexandru⁴,Spătaru Radu-Iulian⁴

Affiliation:

1. Neonatal Intensive Care Unit, ‘Marie S. Curie’ Emergency Clinical Hospital for Children, 077120 Bucharest, Romania

2. Department of Pediatrics, ‘Carol Davila’ University of Medicine and Pharmacy, 050474 Bucharest, Romania

3. Radiology Department, ‘Marie S. Curie’ Emergency Clinical Hospital for Children, 077120 Bucharest, Romania

4. Pediatric Surgery Department, ‘Marie S. Curie’ Emergency Clinical Hospital for Children, 077120 Bucharest, Romania

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sirolimus for vascular anomalies in the first year of life: a systematic review;Journal of Perinatology;2024-01-20

2. Mammalian target of rapamycin inhibitors: A new‐possible approach for in‐utero medication therapy;Prenatal Diagnosis;2024-01

3. Designs used in published therapeutic studies of rare superficial vascular anomalies: a systematic literature search;BMC Medical Research Methodology;2023-08-30

4. Research Status of Clinical Treatment of Infantile Hemangioma;Advances in Clinical Medicine;2023

5. Successful immunosuppressive treatment of chyloperitoneum in the newborn infant with multiple congenital anomalies;Russian Pediatric Journal;2022-10-30